GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Victrex PLC (LSE:VCT) » Definitions » Cash And Cash Equivalents
中文

Victrex (LSE:VCT) Cash And Cash Equivalents

: £30.0 Mil (As of Sep. 2023)
View and export this data going back to 1995. Start your Free Trial

Victrex's quarterly cash and cash equivalents declined from Sep. 2022 (£55.90 Mil) to Mar. 2023 (£38.30 Mil) but then stayed the same from Mar. 2023 (£38.30 Mil) to Sep. 2023 (£30.00 Mil).

Victrex's annual cash and cash equivalents declined from Sep. 2021 (£62.40 Mil) to Sep. 2022 (£55.90 Mil) and declined from Sep. 2022 (£55.90 Mil) to Sep. 2023 (£30.00 Mil).


Victrex Cash And Cash Equivalents Historical Data

The historical data trend for Victrex's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Victrex Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only Premium Member Only 72.50 67.50 62.40 55.90 30.00

Victrex Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 62.40 45.70 55.90 38.30 30.00

Victrex Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Victrex  (LSE:VCT) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Victrex Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Victrex's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Victrex (LSE:VCT) Business Description

Industry
Traded in Other Exchanges
Address
Victrex Technology Centre, Hillhouse International, Thornton Cleveleys, Lancashire, GBR, FY5 4QD
Victrex is a British specialty chemicals company whose business is based predominantly on manufacturing and creating solutions using polyetheretherketone, or PEEK, an ultra-high-performance lightweight plastic. Around 40% of sales are generated in Europe, with Asia and the Americas contributing 30% each. The business has two segments. The industrial segment targets transportation, energy, electronics, and manufacturing, while the medical segment provides healthcare solutions for the implantable device markets.

Victrex (LSE:VCT) Headlines

No Headlines